Specific features of small cell lung cancer in women: social characteristics, medical history, management and survival. A retrospective study of the 967 cases diagnosed in Bas-Rhin (Eastern France) between 1981 and 1994

B. Mennecier, L. Moreau, M. P. Lebitasy, R. Kessler, G. Pauli, E. Quoix (Strasbourg, France)

Source: Annual Congress 2002 - Thoracic oncology: clinical management
Session: Thoracic oncology: clinical management
Session type: Poster Discussion
Number: 1191
Disease area: Thoracic oncology

Congress or journal article abstract

Abstract

Lung cancer represents since the early 90's a major public health problem in both sexes. Some data in literature make it clear that specific features can be seen in women lung cancers. To determine if such particularities could be observed in small cell lung cancers (SCLC), we reviewed the medical charts of all consecutive patients diagnosed with SCLC in the French eastern area of Bas-Rhin between 1981 and 1994.
Among the 787 recorded patients (696 men and 91 women) there was no significant difference as far as age and previous vascular, pulmonary and neoplastic history were concerned. But women living in urban environment were more numerous (59.6% vs 46.2%; p=0.017), as well as single, divorced and widows (30.8% vs 16.9%;p=0.007). Women were more frequently nonsmokers (8.8% vs 1.4%;p=0.003) and among smoking women, smoke exposure was inferior to the one reported by men (p=0.0001).
No significant difference could be noted with reference to the presentation of the disease, the degree of extent and metastatic sites. LDH levels were found more frequently elevated in women (p=0.03). Management and diagnosis procedures were similar in both groups except for bone marrow biopsies which were more often performed in men (p=0.004). Women tended to stay in hospital longer than men (p=0.057), especially due to treatment related complications. Survival was also similar (median 8.1 months in men and 7.9 months in women) irrespectively of any adjustment on other prognostic variables.
So we have shown some specific features in woman small cell lung cancer. However, whether they are related to a real difference -genetic and endocrine susceptibility- or more simply to a different exposure to carcinogens remains to be proven.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. Mennecier, L. Moreau, M. P. Lebitasy, R. Kessler, G. Pauli, E. Quoix (Strasbourg, France). Specific features of small cell lung cancer in women: social characteristics, medical history, management and survival. A retrospective study of the 967 cases diagnosed in Bas-Rhin (Eastern France) between 1981 and 1994. Eur Respir J 2002; 20: Suppl. 38, 1191

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Epidemiology of surgically treated lung cancer in Lorraine, France: 1988-2005. The CRB cohort study
Source: Eur Respir J 2006; 28: Suppl. 50, 385s
Year: 2006

Smoking status in Danish lung cancer patients compared to the general population, 2005 - 2013
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016


Analysis of epidemiological differences and occupations risk of lung cancer cases between 1995-2008 years in Turkey
Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer
Year: 2009


Recurrence of tuberculosis into 2 years after new pulmonary TB cases curred. An observational study 2000-2005, Iasi, Romania
Source: Annual Congress 2008 - Outcomes of tuberculosis treatment
Year: 2008


Invasive aspergillosis (IA) in autopsy material in patients (pts) treated in the national TB and lung diseases research institute in years 1993 - 2000
Source: Eur Respir J 2002; 20: Suppl. 38, 355s
Year: 2002

Patients with a lung cancer are changed: About a French monocentric cohort between 1990 and 2010
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011

Accounting total direct cost of lung cancer inpatients in Iran, 2005 (in Masih Daneshvari hospital)
Source: Annual Congress 2009 - Epidemiology and management of lung cancer
Year: 2009

The influence of risk factors on natural history of children‘s primary tuberculosis observed in patients hospitalized in the clinic between 1973-2002
Source: Eur Respir J 2005; 26: Suppl. 49, 415s
Year: 2005

Comparative epidemiology of lung cancer (prevalence, histology, stage at diagnosis and resectability rate) in North Teesside (UK) and in the Province of Varese (Italy)
Source: Eur Respir J 2001; 18: Suppl. 33, 477s
Year: 2001

A comparison of patients with newly-diagnosed NSCLC between 3 metropolitan hospitals in Melbourne, Australia between 2012-2014.
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017


Time trends in surgery for lung cancer in France from 2005 to 2012: a nationwide study
Source: Eur Respir J 2015; 46: 1131-1139
Year: 2015



Changing incidence of pneumonia diagnosis in UK primary care from 2002-2017: Population-based cohort study
Source: International Congress 2019 – Severe pneumonia: epidemiology, mechanisms and treatment
Year: 2019


TB relapse treatment results in Iasi County (Romania): a cohort study 1998-2005
Source: Annual Congress 2007 - Tuberculosis control
Year: 2007


Study of patients with lung cancer treated surgically in Albania during the period 2000-2003
Source: Annual Congress 2009 - Treatment of lung cancer
Year: 2009

Hospital based study of passive smoking in female lung cancer (LC) patients in Serbia and Montenegro
Source: Eur Respir J 2006; 28: Suppl. 50, 469s
Year: 2006

Changes in the incidence, prevalence and mortality of bronchiectasis in the UK from 2004 to 2013: a population-based cohort study
Source: Eur Respir J 2016; 47: 186-193
Year: 2016



The respiratory health of women (Moscow study, 1991 year and 2001 year)
Source: Eur Respir J 2003; 22: Suppl. 45, 111s
Year: 2003

Comparing cost of different drugs protocols in treatment lung cancer in Iran, 2005 (in Masih Daneshvari hospital)
Source: Annual Congress 2009 - Management of thoracic malignancies
Year: 2009

COPD in Scotland an increasing burden to the hospital sector - a five year retrospective study 1997-2001
Source: Eur Respir J 2004; 24: Suppl. 48, 143s
Year: 2004

Survival trend of patients with lung cancer (LC) in Cáceres (Spain) (1991-2003). Analysis based on TNM staging, histology, modality-treatment and time-period of diagnosis
Source: Eur Respir J 2007; 30: Suppl. 51, 669s
Year: 2007